{"id":"https://openalex.org/W4362544906","doi":"https://doi.org/10.1158/1535-7163.c.6539394","title":"Data from Arsenic Trioxide and Sorafenib Induce Synthetic Lethality of FLT3-ITD Acute Myeloid Leukemia Cells","display_name":"Data from Arsenic Trioxide and Sorafenib Induce Synthetic Lethality of FLT3-ITD Acute Myeloid Leukemia Cells","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362544906","doi":"https://doi.org/10.1158/1535-7163.c.6539394"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.c.6539394","doi":"https://doi.org/10.1158/1535-7163.c.6539394","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.c.6539394","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1535-7163.c.6539394","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100431270","display_name":"Rui Wang","orcid":"https://orcid.org/0000-0002-5415-086X","observed_orcids":["https://orcid.org/0000-0002-5415-086X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rui Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100414179","display_name":"Ying Li","orcid":"https://orcid.org/0000-0002-2693-6056","observed_orcids":["https://orcid.org/0000-0002-2693-6056"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ying Li","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101071638","display_name":"Ping Gong","orcid":"https://orcid.org/0000-0002-4663-4098","observed_orcids":["https://orcid.org/0000-0002-4663-4098","https://orcid.org/0000-0002-9266-3295"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ping Gong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062295987","display_name":"Janice Lynn Gabrilove","orcid":"https://orcid.org/0000-0002-2967-4493","observed_orcids":["https://orcid.org/0000-0002-2967-4493"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Janice Gabrilove","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103695409","display_name":"Samuel Waxman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Samuel Waxman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5013338910","display_name":"Yongkui Jing","orcid":"https://orcid.org/0000-0002-7915-8593","observed_orcids":["https://orcid.org/0000-0002-7915-8593"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yongkui Jing","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12582","display_name":"Flavonoids in Medical Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/arsenic-trioxide","display_name":"arsenic trioxide","score":0.8840000033378601},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":1.0},{"id":"https://openalex.org/keywords/flt3-itd-mutation","display_name":"FLT3-ITD","score":0.9319999814033508},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9980000257492065},{"id":"https://openalex.org/keywords/synthetic-lethality","display_name":"synthetic lethality","score":0.9900000095367432},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.9409999847412109},{"id":"https://openalex.org/keywords/mcl-1","display_name":"Mcl-1","score":0.9179999828338623},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8700000047683716},{"id":"https://openalex.org/keywords/glycogen-synthase-kinase-3beta","display_name":"glycogen synthase kinase-3\u03b2","score":0.8790000081062317},{"id":"https://openalex.org/keywords/reduced-glutathione","display_name":"reduced glutathione","score":0.9300000071525574},{"id":"https://openalex.org/keywords/bak","display_name":"Bak","score":0.6439999938011169},{"id":"https://openalex.org/keywords/bax","display_name":"Bax","score":0.984000027179718},{"id":"https://openalex.org/keywords/flt3-inhibitors","display_name":"FLT3 inhibitors","score":0.531000018119812},{"id":"https://openalex.org/keywords/xenograft-survival","display_name":"xenograft survival","score":0.7329999804496765}],"concepts":[{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.861904501914978},{"id":"https://openalex.org/C2780386689","wikidata":"https://www.wikidata.org/wiki/Q7739","display_name":"Arsenic trioxide","level":3,"score":0.859038770198822},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6159639954566956},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.6074066758155823},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.44504547119140625},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.43335187435150146},{"id":"https://openalex.org/C2776481607","wikidata":"https://www.wikidata.org/wiki/Q6842945","display_name":"Midostaurin","level":3,"score":0.42512550950050354},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.4191061854362488},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.40696120262145996},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.366929292678833},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20495688915252686},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.11448457837104797},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.c.6539394","doi":"https://doi.org/10.1158/1535-7163.c.6539394","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.c.6539394","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.c.6539394","doi":"https://doi.org/10.1158/1535-7163.c.6539394","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.c.6539394","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2809791201","https://openalex.org/W4362528191","https://openalex.org/W2594408004","https://openalex.org/W2560127522","https://openalex.org/W4362528561","https://openalex.org/W4362528735","https://openalex.org/W2592823022","https://openalex.org/W2889405992","https://openalex.org/W4362528194","https://openalex.org/W2013966534"],"abstract_inverted_index":{"Abstract":[0],"Acute":[1],"myeloid":[2],"leukemia":[3],"(AML)":[4],"with":[5,136,155,161],"Fms-related":[6],"tyrosine":[7],"kinase":[8,45,124,128],"3":[9],"internal":[10],"tandem":[11],"duplication":[12],"(FLT3-ITD)":[13],"mutation":[14],"is":[15,134,139,142],"notoriously":[16],"hard":[17],"to":[18,92,94,173],"treat.":[19],"We":[20,87],"identified":[21],"two":[22],"drugs":[23],"that":[24],"together":[25],"form":[26,120],"an":[27,39,48,108],"effective":[28],"combination":[29,164,170],"therapy":[30,180],"against":[31],"FLT3-ITD":[32,42,54,70,156],"AML.":[33],"One":[34],"of":[35,41,69,97,116,121,178,181],"the":[36,67,114,117,162,175],"drugs,":[37],"Sorafenib,":[38,137],"inhibitor":[40],"and":[43,71,74,81,145,149],"other":[44],"activity,":[46],"produces":[47],"impressive":[49],"but":[50],"short-lived":[51],"remission":[52],"in":[53,77,82],"AML":[55,182],"patients.":[56,183],"The":[57],"second,":[58],"arsenic":[59],"trioxide":[60],"(ATO),":[61],"at":[62],"therapeutically":[63],"achievable":[64],"concentrations,":[65],"reduces":[66],"level":[68],"Mcl-1":[72,141],"proteins,":[73],"induces":[75],"apoptosis":[76],"leukemic":[78],"cell":[79,158],"lines":[80],"primary":[83],"cells":[84],"expressing":[85],"FLT3-ITD.":[86],"linked":[88],"this":[89],"relative":[90],"sensitivity":[91],"ATO":[93,104,133],"low":[95],"levels":[96],"reduced":[98],"glutathione.":[99],"While":[100],"producing":[101],"proapoptotic":[102,146],"effects,":[103],"treatment":[105],"also":[106],"has":[107,171],"unwanted":[109],"effect":[110],"whereby":[111],"it":[112],"causes":[113],"accumulation":[115],"phosphorylated":[118],"(inactive)":[119],"glycogen":[122],"synthase":[123],"3\u03b2":[125],"(GSK3\u03b2),":[126],"a":[127],"necessary":[129],"for":[130],"apoptosis.":[131],"When":[132],"combined":[135],"GSK3\u03b2":[138],"activated,":[140],"further":[143],"reduced,":[144],"proteins":[147],"Bak":[148],"Bax":[150],"are":[151],"activated.":[152],"Mice":[153],"xenografted":[154],"MOLM13":[157],"line":[159],"treated":[160],"Sorafenib/ATO":[163],"have":[165],"significantly":[166],"improved":[167],"survival.":[168],"This":[169],"potential":[172],"improve":[174],"therapeutic":[176],"outcome":[177],"FLT3-ITD\u2013targeted":[179],"Mol":[184],"Cancer":[185],"Ther;":[186],"17(9);":[187],"1871\u201380.":[188],"\u00a92018":[189],"AACR.":[190]},"counts_by_year":[],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2023-04-06T00:00:00"}